Search

Your search keyword '"Estimación de Kaplan-Meier"' showing total 28 results

Search Constraints

Start Over You searched for: Descriptor "Estimación de Kaplan-Meier" Remove constraint Descriptor: "Estimación de Kaplan-Meier"
28 results on '"Estimación de Kaplan-Meier"'

Search Results

1. Survival analysis and associated factors of highgrade glioma patients.

2. Survival analysis and associated factors of highgrade glioma patients

3. APLICACIÓN DE MODELOS PARAMÉTRICOS ALTERNATIVOS PARA EL ANÁLISIS DE SUPERVIVENCIA DE PACIENTES CON CÁNCER.

4. Supervivencia al cáncer infantil en Manizales, 2008-2020: estudio de base poblacional.

5. 2B2 - Supervivencia al cáncer infantil en Manizales, 2008-2020: estudio de base poblacional.

6. Câncer de Próstata: análise de sobrevida e fatores prognósticos por faixa etária de diagnóstico

7. Del juicio clínico al análisis de supervivencia.

8. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

9. Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)

10. Supervivencia a 6 meses de pacientes con alguna patología nefrológica atendidos en una Unidad de Emergencia de un hospital general de Perú

11. HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

12. Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients

13. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling

14. Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database

15. Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

16. Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

17. Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

18. Influence of Gender on Long-term Prognosis of Patients With Chronic Heart Failure Seen in Heart Failure Clinics

19. Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

20. CLOCK gene variation is associated with incidence of type‑2 diabetes and cardiovascular diseases in type‑2 diabetic subjects: dietary modulation in the PREDIMED randomized trial

21. Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice : a retrospective cross-sectional analysis

22. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

23. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia

24. Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in Meniere's disease

25. Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

26. Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus

27. Sobrevida y complicaciones del paciente con injerto renal de donante cadavérico vs. donante vivo, controlados en el hospital 'José Carrasco Arteaga' (IESS). Cuenca. 2007 marzo 2012

28. Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

Catalog

Books, media, physical & digital resources